These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18003614)

  • 21. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor α Coactivator.
    Shalom-Barak T; Liersemann J; Memari B; Flechner L; Devor CE; Bernardo TM; Kim S; Matsumoto N; Friedman SL; Evans RM; White JH; Barak Y
    Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ.
    Kilu W; Merk D; Steinhilber D; Proschak E; Heering J
    J Biol Chem; 2021 Jul; 297(1):100814. PubMed ID: 34081964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
    Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoid X receptor alpha (RXRalpha) helix 12 plays an inhibitory role in the recruitment of the p160 co-activators by unliganded RXRalpha/retinoic acid receptor alpha heterodimers.
    Liu H; Shaw CK; Reineke EL; Liu Y; Kao HY
    J Biol Chem; 2004 Oct; 279(43):45208-18. PubMed ID: 15310754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
    Thompson PD; Remus LS; Hsieh JC; Jurutka PW; Whitfield GK; Galligan MA; Encinas Dominguez C; Haussler CA; Haussler MR
    J Mol Endocrinol; 2001 Oct; 27(2):211-27. PubMed ID: 11564604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylated retinoid X receptor alpha loses its heterodimeric activity with retinoic acid receptor beta.
    Yoshimura K; Muto Y; Shimizu M; Matsushima-Nishiwaki R; Okuno M; Takano Y; Tsurumi H; Kojima S; Okano Y; Moriwaki H
    Cancer Sci; 2007 Dec; 98(12):1868-74. PubMed ID: 17900311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid receptor-interacting protein-1 and receptor-associated coactivator-3 differentially interact with the vitamin D receptor (VDR) and regulate VDR-retinoid X receptor transcriptional cross-talk.
    Issa LL; Leong GM; Barry JB; Sutherland RL; Eisman JA
    Endocrinology; 2001 Apr; 142(4):1606-15. PubMed ID: 11250942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation.
    Whitfield GK; Hsieh JC; Nakajima S; MacDonald PN; Thompson PD; Jurutka PW; Haussler CA; Haussler MR
    Mol Endocrinol; 1995 Sep; 9(9):1166-79. PubMed ID: 7491109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of RAS/ERK alone is insufficient to inhibit RXRα function and deplete retinoic acid in hepatocytes.
    Wang AG; Song YN; Chen J; Li HL; Dong JY; Cui HP; Yao L; Li XF; Gao WT; Qiu ZW; Wang FJ; Wang JY
    Biochem Biophys Res Commun; 2014 Sep; 452(3):801-7. PubMed ID: 25218146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
    Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
    J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
    Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D-induced up-regulation of human keratinocyte cathelicidin anti-microbial peptide expression involves retinoid X receptor α.
    Svensson D; Nebel D; Voss U; Ekblad E; Nilsson BO
    Cell Tissue Res; 2016 Nov; 366(2):353-362. PubMed ID: 27357804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.
    Wang N; Zou Q; Xu J; Zhang J; Liu J
    J Biol Chem; 2018 Nov; 293(47):18180-18191. PubMed ID: 30275017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of heterodimerization by 1alpha,25-dihydroxyvitamin D(3) and its 20-epi analog.
    Liu YY; Nguyen C; Ali Gardezi SA; Schnirer I; Peleg S
    Steroids; 2001; 66(3-5):203-12. PubMed ID: 11179727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ; Brown G
    J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
    Jensen TJ; Henriksen LO; Sølvsten H; Kragballe K
    Biochem Pharmacol; 1998 Mar; 55(6):767-73. PubMed ID: 9586948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1.
    Gill RK; Atkins LM; Hollis BW; Bell NH
    Mol Endocrinol; 1998 Jan; 12(1):57-65. PubMed ID: 9440810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
    Matkovits T; Christakos S
    Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.